Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cancer Chemotherapy and Pharmacology

• Publication date

  2004-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00280-003-0742-5PMID 14666379
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Experimental chemotherapy against xenografts derived from multidrug resistant KBv200 cells and parental drug-sensitive KB cells in nude mice by annonaceous acetogenin 89-2.

  2003cited by this paper
• Structure-activity studies of substituted quinoxalinones as multiple-drug-resistance antagonists.

  2001cited by this paper
• Constructing History in Biography: A Symposium on William Osler: A Life in Medicine: Introduction

  2001cited by this paper
• Structure-activity relationships of multidrug resistance reversers.

  2001cited by this paper
• Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance.

  2000cited by this paper
• Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs.

  2000cited by this paper
• Multidrug resistance of acute leukemia and a strategy to overcome it.

  2000cited by this paper
• Reversal of multidrug resistance of tumor cells.

  2000cited by this paper
• The prognostic significance of membrane transport-associated multidrug resistance (MDR) proteins in leukemia.

  2000cited by this paper
• Establishment of the model of KBv200 nude mice xenograft and studies on its characterization of multidrug resistance

  2000cited by this paper
• Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter.

  1999cited by this paper
• Phase I clinical and pharmacokinetic study of S9788, a new multidrug-resistance reversal agent given alone and in combination with doxorubicin to patients with advanced solid tumors

  1998cited by this paper
• PSC-833, a frontier in modulation of P-glycoprotein mediated multidrug resistance

  1998cited by this paper
• Multidrug resistance and its reversal.

  1998cited by this paper
• Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein

  1997cited by this paper
• Cellular and biochemical characterization of VX-710 as a chemosensitizer: reversal of P-glycoprotein-mediated multidrug resistance in vitro.

  1997cited by this paper
• Pharmacological characterization of LY335979: a potent cyclopropyldibenzosuberane modulator of P-glycoprotein.

  1997cited by this paper
• Multidrug resistance: molecular mechanisms and clinical relevance

  1997cited by this paper
• Reversal of multidrug resistance-associated protein-mediated drug resistance by the pyridine analog PAK-104P.

  1997cited by this paper
• Pharmacologic approaches to reversing multidrug resistance.

  1997cited by this paper
• Cellular drug efflux and reversal therapy of cancer

  1996cited by this paper
• Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979.

  1996cited by this paper
• Multidrug resistance in leukemias and its reversal.

  1996cited by this paper
• [Vincristine-resistant human KB cell line and mechanism of multidrug resistance].

  1994cited by this paper
• In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative.

  1993cited by this paper
• Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance.

  1993cited by this paper
• Plasma membrane lipid composition of vinblastine sensitive and resistant human leukaemic lymphoblasts

  1988cited by this paper
• Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.

  1987cited by this paper
• Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity.

  1987cited by this paper
• Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.

  1981cited by this paper

• Emerging Multifunctional Biomaterials for Addressing Drug Resistance in Cancer

  2025cites this paper
• Critical review and future perspectives on the anticancer effects of Stephania tetrandra S. Moore

  2025cites this paper
• A Comprehensive Appraisal of Bisbenzylisoquinoline Alkaloids Isolated From Genus Cyclea for Anticancer Potential

  2025cites this paper
• Medicinal plants as a potential resource for the discovery of novel structures towards cancer drug resistance treatment

  2024cites this paper
• Tetrandrine for Targeting Therapy Resistance in Cancer.

  2024cites this paper
• Insights on exploring the therapeutic potential and structural modification of Tetrandrine.

  2024cites this paper
• Advances in glioblastoma multiforme: Integrating therapy and pathology perspectives.

  2024cites this paper
• Controllable release of self-assembled reduction-sensitive paclitaxel dimer prodrug and tetrandrine nanoparticles promotes synergistic therapy against multidrug-resistant cancer.

  2023cites this paper
• Simplified Derivatives of Tetrandrine as Potent and Specific P-gp Inhibitors to Reverse Multidrug Resistance in Cancer Chemotherapy.

  2023cites this paper
• Reversal Effect of Saikosaponin A and Saikosaponin B on Doxorubicin-resistant Breast Cancer Cells and its Mechanism

  2023cites this paper
• Dual-Drug Delivery by Anisotropic and Uniform Hybrid Nanostructures: A Comparative Study of the Function and Substrate–Drug Interaction Properties

  2023influential citation
• The Tetrahydroisoquinoline Scaffold in ABC Transporter Inhibitors that Act as Multidrug Resistance (MDR) Reversers.

  2022cites this paper
• Lazertinib improves the efficacy of chemotherapeutic drugs in ABCB1 or ABCG2 overexpression cancer cells in vitro, in vivo, and ex vivo

  2022cites this paper
• A Worldwide Bibliometric Analysis of Tetrandrine Research in Recent Two Decades

  2022cites this paper
• An updated review on therapeutic potential and recent advances in drug delivery of Berberine: Current status and future prospect.

  2021cites this paper
• Phytochemicals reverse P-glycoprotein mediated multidrug resistance via signal transduction pathways.

  2021cites this paper
• Reversal of ABCB1-related multidrug resistance by ERK5-IN-1

  2020cites this paper
• Rociletinib (CO-1686) enhanced the efficacy of chemotherapeutic agents in ABCG2-overexpressing cancer cells in vitro and in vivo

  2020cites this paper
• Hypocrellin B triggered sonodynamic therapy reverses multidrug resistance of doxorubicin-resistant SGC7901/ADR cells via down-regulation of P-gp expression

  2020cites this paper
• Synthesis, biological evaluation and toxicity of novel tetrandrine analogues

  2020cites this paper
• Pharmacokinetics of 10-hydroxycamptothecin-tetrandrine liposome complexes in rat by a simple and sensitive ultra-high performance liquid chromatography tandem with mass spectrometry.

  2019cites this paper
• Imatinib enhances the anti-tumour effect of doxorubicin in canine B-cell lymphoma cell line.

  2019cites this paper
• Antitumor activity of tetrandrine citrate in human glioma U87 cells in vitro and in vivo

  2019cites this paper
• Medicinal Plants as a Source of Alkaloids

  2019cites this paper
• Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo

  2019cites this paper
• Teratogenic jervine increases the activity of doxorubicin in MCF-7/ADR cells by inhibiting ABCB1.

  2019cites this paper
• Natural products as multidrug resistance modulators in cancer.

  2019cites this paper
• Polymeric Micelles in Management of Lung Cancer

  2019cites this paper
• Targeting multidrug resistance in cancer by natural chemosensitizers

  2019cites this paper
• Flavonoids as P-gp inhibitors: a systematic review of SARs.

  2019cites this paper
• Synthesis and biological evaluation of novel H6 analogues as drug resistance reversal agents.

  2019cites this paper
• PCI29732, a Bruton’s Tyrosine Kinase Inhibitor, Enhanced the Efficacy of Conventional Chemotherapeutic Agents in ABCG2-Overexpressing Cancer Cells

  2018cites this paper
• Design and synthesis of novel C14-urea-tetrandrine derivatives with potent anti-cancer activity.

  2018cites this paper
• Ceritinib Enhances the Efficacy of Substrate Chemotherapeutic Agent in Human ABCB1-Overexpressing Leukemia Cells In Vitro, In Vivo and Ex-Vivo

  2018cites this paper
• Tetrandrine and cancer - An overview on the molecular approach.

  2018cites this paper
• Tetrandrine and cancer – An overview on the molecular approach

  2018cites this paper
• Olmutinib (HM61713) reversed multidrug resistance by inhibiting the activity of ATP-binding cassette subfamily G member 2 in vitro and in vivo

  2018cites this paper
• Tetrandrine reverses the drug resistance of colon cancer to 5-fluorouracil

  2017cites this paper
• Hybrid Prodrug Nanoparticles with Tumor Penetration and Programmed Drug Activation for Enhanced Chemoresistant Cancer Therapy.

  2017cites this paper
• Reduction-sensitive Paclitaxel Prodrug Self-assembled Nanoparticles with Tetrandrine Effectively Promote Synergistic Therapy Against Drug-sensitive and Multidrug-resistant Breast Cancer.

  2017cites this paper
• The effect of saikosaponin D on doxorubicin pharmacokinetics and its MDR reversal in MCF-7/adr cell xenografts.

  2017cites this paper
• Reversal of P-gp-mediated multidrug resistance in colon cancer by cinobufagin.

  2017cites this paper
• Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.

  2017cites this paper
• Targeting P-glycoprotein: Investigation of piperine analogs for overcoming drug resistance in cancer

  2017cites this paper
• Effect of abemaciclib (LY2835219) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo

  2017cites this paper
• Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells

  2017cites this paper
• Tetrandrine potentiates the glucocorticoid pharmacodynamics via inhibiting P‐glycoprotein and mitogen‐activated protein kinase in mitogen‐activated human peripheral blood mononuclear cells

  2017cites this paper
• Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo

  2017cites this paper
• Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer.

  2017cites this paper
• Determination of a novel anticancer AMPK activator hernandezine in rat plasma and tissues with a validated UHPLC–MS/MS method: Application to pharmacokinetics and tissue distribution study

  2017cites this paper
• Hernandezine, a Bisbenzylisoquinoline Alkaloid with Selective Inhibitory Activity against Multidrug-Resistance-Linked ATP-Binding Cassette Drug Transporter ABCB1.

  2016cites this paper
• Molecular docking study of natural alkaloids as multi-targeted hedgehog pathway inhibitors in cancer stem cell therapy

  2016cites this paper
• The development of a quantitative and qualitative method based on UHPLC-QTOF MS/MS for evaluation paclitaxel-tetrandrine interaction and its application to a pharmacokinetic study.

  2016cites this paper
• Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy

  2016cites this paper
• P-Glycoprotein Mediated Multidrug Resistance Reversal by Phytochemicals: A Review of SAR & Future Perspective for Drug Design.

  2016cites this paper
• Osimertinib (AZD9291) Enhanced the Efficacy of Chemotherapeutic Agents in ABCB1- and ABCG2-Overexpressing Cells In Vitro, In Vivo, and Ex Vivo

  2016cites this paper
• Transporter modulation by Chinese herbal medicines and its mediated pharmacokinetic herb-drug interactions.

  2016cites this paper
• Research progress on berberine with a special focus on its oral bioavailability.

  2016cites this paper
• Nanotechnology for cancer therapy

  2016cites this paper
• Cetuximab enhanced the efficacy of chemotherapeutic agent in ABCB1/P-glycoprotein-overexpressing cancer cells

  2015influential citation
• Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo

  2015cites this paper
• Fentanyl Enhances Hepatotoxicity of Paclitaxel via Inhibition of CYP3A4 and ABCB1 Transport Activity in Mice

  2015cites this paper
• Targeted multidrug-resistance reversal in tumor based on PEG-PLL-PLGA polymer nano drug delivery system

  2015cites this paper
• Tetrandrine Inhibits the Intracellular Calcium Ion Level and Upregulates the Expression of Brg1 and AHNAK in Hep-2 Cells.

  2015cites this paper
• Multifunctional mesoporous silica nanoparticles mediated co-delivery of paclitaxel and tetrandrine for overcoming multidrug resistance.

  2015cites this paper
• Cinnamaldehyde Derivative (CB-PIC) Sensitizes Chemo-Resistant Cancer Cells to Drug-Induced Apoptosis via Suppression of MDR1 and its Upstream STAT3 and AKT Signalling

  2015cites this paper
• Lapatinib promotes the incidence of hepatotoxicity by increasing chemotherapeutic agent accumulation in hepatocytes

  2015cites this paper
• Reversal of P-glycoprotein-mediated multidrug resistance by the novel tetrandrine derivative W6

  2015cites this paper
• Discovery and Computer-Aided Drug Design Studies of the Anticancer Marine Triterpene Sipholanes as Novel P-gp and Brk Modulators

  2015cites this paper
• UMMS-4 enhanced sensitivity of chemotherapeutic agents to ABCB1-overexpressing cells via inhibiting function of ABCB1 transporter.

  2014influential citation
• CEP-33779 antagonizes ATP-binding cassette subfamily B member 1 mediated multidrug resistance by inhibiting its transport function.

  2014influential citation
• Anticancer and multidrug-resistance reversing potential of traditional medicinal plants and their bioactive compounds in leukemia cell lines.

  2014cites this paper
• Compounds from Chinese herbal medicines as reversal agents for P-glycoprotein-mediated multidrug resistance in tumours

  2014cites this paper
• Tetrandrine enhances the anticancer effects of arsenic trioxide in vitro.

  2014cites this paper
• Lapatinib Antagonizes Multidrug Resistance-Associated Protein 1-Mediated Multidrug Resistance by Inhibiting Its Transport Function

  2014cites this paper
• Afatinib circumvents multidrug resistance via dually inhibiting ATP binding cassette subfamily G member 2 in vitro and in vivo

  2014cites this paper
• Tandutinib (MLN518/CT53518) targeted to stem-like cells by inhibiting the function of ATP-binding cassette subfamily G member 2.

  2013cites this paper
• Reversal effects of Rabdosia rubescens extract on multidrug resistance of MCF-7/Adr cells in vitro

  2013cites this paper
• Secalonic acid D reduced the percentage of side populations by down-regulating the expression of ABCG2.

  2013cites this paper
• Tetrandrine exerts antidepressant-like effects in animal models: role of brain-derived neurotrophic factor.

  2013cites this paper
• Multidrug Resistance in Cancer: A Tale of ABC Drug Transporters

  2013cites this paper
• Yeast as a biosensor of detoxification: a tool for identifying new compounds that revert multidrug resistance.

  2013cites this paper
• Berberine analogue IMB-Y53 improves glucose-lowering efficacy by averting cellular efflux especially P-glycoprotein efflux.

  2013influential citation
• Multifunctional and multitargeted nanoparticles for drug delivery to overcome barriers of drug resistance in human cancers.

  2013cites this paper
• Saracatinib (AZD0530) is a potent modulator of ABCB1‐mediated multidrug resistance in vitro and in vivo

  2013cites this paper
• ABCB1-overexpressing MG63/DOX cell xenograft model: Maintain the MDR phenotype in vivo

  2013cites this paper
• Tetrandrine potentiates the hypoglycemic efficacy of berberine by inhibiting P-glycoprotein function.

  2013cites this paper
• Axitinib Targeted Cancer Stemlike Cells to Enhance Efficacy of Chemotherapeutic Drugs via Inhibiting the Drug Transport Function of ABCG2

  2012cites this paper
• Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo

  2012cites this paper
• BBA, a derivative of 23-hydroxybetulinic acid, potently reverses ABCB1-mediated drug resistance in vitro and in vivo.

  2012cites this paper
• Multifunctional magnetic Fe3O4 nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance

  2012cites this paper
• Partial synthesis and biological evaluation of bisbenzylisoquinoline alkaloids derivatives: potential modulators of multidrug resistance in cancer

  2012cites this paper
• Synthesis and evaluation of (2-(4-methoxyphenyl)-4-quinolinyl)(2-piperidinyl)methanol (NSC23925) isomers to reverse multidrug resistance in cancer.

  2012cites this paper
• ABCG2-overexpressing S1-M1-80 cell xenografts in nude mice keep original biochemistry and cell biological properties

  2012cites this paper
• The Multidrug Resistant Modulator HZ08 Reverses Multidrug Resistance via P-glycoprotein Inhibition and Apoptosis Sensitization in Human Epidermoid Carcinoma Cell Line KBv200

  2012cites this paper
• Three decades of P-gp inhibitors: skimming through several generations and scaffolds.

  2012cites this paper
• Crizotinib (PF‐02341066) reverses multidrug resistance in cancer cells by inhibiting the function of P‐glycoprotein

  2012influential citation
• Tetrandrine enhances cytotoxicity of cisplatin in human drug-resistant esophageal squamous carcinoma cells by inhibition of multidrug resistance-associated protein 1.

  2012cites this paper
• Secondary Metabolites from Plants Inhibiting ABC Transporters and Reversing Resistance of Cancer Cells and Microbes to Cytotoxic and Antimicrobial Agents

  2012cites this paper
• Alkaloids Isolated from Natural Herbs as the Anticancer Agents

  2012cites this paper